| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.83B | 58.56B | 60.11B | 61.74B | 62.18B | 53.17B |
| Gross Profit | 23.81B | 24.98B | 23.84B | 25.31B | 25.74B | 21.50B |
| EBITDA | 8.95B | 9.96B | 9.23B | 9.90B | 11.55B | 9.68B |
| Net Income | 4.64B | 5.13B | 4.68B | 4.91B | 6.75B | 4.84B |
Balance Sheet | ||||||
| Total Assets | 77.02B | 83.41B | 79.00B | 74.91B | 68.95B | 60.51B |
| Cash, Cash Equivalents and Short-Term Investments | 7.26B | 7.92B | 7.97B | 6.39B | 8.19B | 8.14B |
| Total Debt | 13.54B | 16.99B | 14.51B | 11.01B | 6.72B | 5.67B |
| Total Liabilities | 27.39B | 29.88B | 28.47B | 26.17B | 23.27B | 19.53B |
| Stockholders Equity | 49.59B | 53.48B | 50.49B | 48.22B | 45.20B | 39.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 572.00M | -1.56B | -3.06B | 1.72B | 2.08B |
| Operating Cash Flow | 0.00 | 5.03B | 4.87B | 1.76B | 4.40B | 5.23B |
| Investing Cash Flow | 0.00 | -4.36B | -4.89B | -4.75B | -1.33B | -3.69B |
| Financing Cash Flow | 0.00 | -902.00M | 1.57B | 923.00M | -3.40B | -1.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥28.34B | 4.94 | ― | 0.72% | 6.51% | 3.68% | |
79 Outperform | ¥278.12B | 7.78 | 8.91% | 3.85% | 5.98% | 39.06% | |
78 Outperform | ¥94.24B | 7.87 | ― | 3.82% | 3.17% | 654.02% | |
73 Outperform | ¥222.73B | 18.03 | ― | 2.50% | 2.57% | 9.10% | |
71 Outperform | ¥107.86B | 15.48 | ― | 4.64% | 1.98% | -17.68% | |
69 Neutral | ¥133.69B | 15.63 | ― | 3.77% | -2.59% | 9.56% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |